CNY 7.26
(0.55%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 147.37 Million CNY | -3.44% |
2022 | 152.62 Million CNY | 6.91% |
2021 | 142.75 Million CNY | 21.99% |
2020 | 117.02 Million CNY | -16.77% |
2019 | 140.59 Million CNY | 133.14% |
2018 | -424.24 Million CNY | 2.52% |
2017 | -435.22 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 38.39 Million CNY | 41.49% |
2024 Q2 | 38.24 Million CNY | -0.37% |
2024 Q3 | 35.5 Million CNY | -7.17% |
2023 Q1 | 34.83 Million CNY | 1.34% |
2023 FY | 147.37 Million CNY | -3.44% |
2023 Q4 | 27.13 Million CNY | -37.77% |
2023 Q3 | 43.6 Million CNY | 4.33% |
2023 Q2 | 41.79 Million CNY | 19.97% |
2022 Q3 | 48.73 Million CNY | 60.23% |
2022 Q2 | 30.41 Million CNY | -22.23% |
2022 Q1 | 39.1 Million CNY | 11.88% |
2022 FY | 152.62 Million CNY | 6.91% |
2022 Q4 | 34.37 Million CNY | -29.46% |
2021 Q2 | 31.87 Million CNY | -16.42% |
2021 Q1 | 38.13 Million CNY | -5.65% |
2021 FY | 142.75 Million CNY | 21.99% |
2021 Q4 | 34.95 Million CNY | -7.5% |
2021 Q3 | 37.78 Million CNY | 18.54% |
2020 Q1 | 10.78 Million CNY | -72.21% |
2020 FY | 117.02 Million CNY | -16.77% |
2020 Q4 | 40.42 Million CNY | -11.01% |
2020 Q3 | 45.42 Million CNY | 122.87% |
2020 Q2 | 20.38 Million CNY | 89.03% |
2019 Q3 | 41.57 Million CNY | 0.0% |
2019 Q4 | 38.79 Million CNY | -6.68% |
2019 FY | 140.59 Million CNY | 133.14% |
2018 FY | -424.24 Million CNY | 2.52% |
2017 FY | -435.22 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Shanghai Runda Medical Technology Co., Ltd. | 273.29 Million CNY | 46.076% |
Joinn Laboratories(China)Co.,Ltd. | 396.99 Million CNY | 62.878% |
WuXi AppTec Co., Ltd. | 9.6 Billion CNY | 98.466% |
Autobio Diagnostics Co., Ltd. | 1.21 Billion CNY | 87.895% |
Thalys Medical Technology Group Inc. | -158.57 Million CNY | 192.938% |
Guangzhou Kingmed Diagnostics Group Co., Ltd. | 643.38 Million CNY | 77.094% |